z-logo
open-access-imgOpen Access
Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer
Author(s) -
Cairu Liu,
Haiqin Feng,
Lihong Song,
Shuirui Li,
Yiping Wu,
Liping Yang
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8384
Subject(s) - hela , viability assay , protein kinase b , pi3k/akt/mtor pathway , cancer research , apoptosis , stat3 , cell cycle , cisplatin , chemistry , medicine , pharmacology , cell , biology , biochemistry , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom